Compass Therapeutics (CMPX) Current Assets (2023 - 2025)
Historic Current Assets for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $221.1 million.
- Compass Therapeutics' Current Assets rose 5666.71% to $221.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.1 million, marking a year-over-year increase of 5666.71%. This contributed to the annual value of $132.8 million for FY2024, which is 1373.14% down from last year.
- According to the latest figures from Q3 2025, Compass Therapeutics' Current Assets is $221.1 million, which was up 5666.71% from $106.2 million recorded in Q2 2025.
- Over the past 5 years, Compass Therapeutics' Current Assets peaked at $221.1 million during Q3 2025, and registered a low of $106.2 million during Q2 2025.
- For the 3-year period, Compass Therapeutics' Current Assets averaged around $156.1 million, with its median value being $153.9 million (2023).
- Within the past 5 years, the most significant YoY rise in Compass Therapeutics' Current Assets was 5666.71% (2025), while the steepest drop was 3083.83% (2025).
- Quarter analysis of 3 years shows Compass Therapeutics' Current Assets stood at $153.9 million in 2023, then fell by 13.73% to $132.8 million in 2024, then soared by 66.57% to $221.1 million in 2025.
- Its Current Assets stands at $221.1 million for Q3 2025, versus $106.2 million for Q2 2025 and $124.1 million for Q1 2025.